CAS 53984-36-4
:Benzoesäure, 3-chlor-5-hydroxy-
- 3-Chloro-5-hydroxybenzoicacid
- 3-Hydroxy-5-chlorobenzoic acid
3-Chloro-5-hydroxybenzoic Acid
CAS:Formel:C7H5ClO3Reinheit:>98.0%(GC)(T)Farbe und Form:White to Orange to Green powder to crystalMolekulargewicht:172.56Benzoic acid, 3-chloro-5-hydroxy-
CAS:Formel:C7H5ClO3Reinheit:97%Farbe und Form:SolidMolekulargewicht:172.56583-chloro-5-hydroxybenzoic Acid
CAS:3-chloro-5-hydroxybenzoic AcidReinheit:≥95%Molekulargewicht:172.57g/mol3-Chloro-5-hydroxybenzoic acid
CAS:3-Chloro-5-hydroxybenzoic acidReinheit:95%Molekulargewicht:172.57g/mol3-chloro-5-hydroxybenzoic Acid
CAS:3-chloro-5-hydroxy Benzoic Acid (3-chloro-5-hydroxy BA) is an agonist of GPR81 (EC50 : 16 μM)Formel:C7H5ClO3Reinheit:98%Farbe und Form:SolidMolekulargewicht:172.573-Chloro-5-hydroxybenzoic acid
CAS:3-Chloro-5-hydroxybenzoic acid is a fluorescent compound that has been used to study insulin resistance in rats. Using fluorescence resonance energy transfer, this study found that 3-chloro-5-hydroxybenzoic acid increases insulin sensitivity and decreases blood pressure levels. It is hypothesized that the observed effects are due to an increase in the uptake of 3,5-dihydroxybenzoic acid into cells, which helps regulate the release of nitric oxide from afferent arterioles. Increased nitric oxide leads to vasodilation and increased uptake of glucose by muscle cells. This mechanism may be responsible for the observed decrease in blood pressure and improved insulin sensitivity.
Formel:C7H5ClO3Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:172.56 g/mol3-Chloro-5-hydroxybenzoic acid
CAS:Formel:C7H5ClO3Reinheit:97%Farbe und Form:SolidMolekulargewicht:172.565-Chloro-m-salicylic Acid
CAS:Kontrolliertes ProduktApplications 5-Chloro-m-salicylic Acid was studied as a potential selective lactate receptor (GPR81) agonists with antilipolytic effects.
References Dvorak, C.A., et al.: ACS. Med. Chem. Lett., 3, 637 (2012);Formel:C7H5ClO3Farbe und Form:NeatMolekulargewicht:172.57






